It Takes a Village…

Abstract

Recent research in new drug treatments for dementia such as anti-amyloid therapies have certainly piqued interest in the future possibilities for dementia pharmacotherapy. However, as with many medicines, the drugs have side effects, are expensive, and the evidence is still evolving. Furthermore, the first principles in any disease state management are prevention and non-pharmacological management. In this editorial, I invite you to look at dementia management based on three pillars. These, in my view, are all equally important. They are preventive and social medicine, medicine (prescribing), and deprescribing.